Literature DB >> 23960730

Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes.

Ola H El-Nesr1, Soad A Yahiya, Omaima N El-Gazayerly.   

Abstract

Fluconazole-entrapped multilamellar liposomes were prepared using the thin-film hydration method. The effects of cholesterol molar ratio, charge-inducing agents, and α-tocopherol acetate on encapsulation efficiency values and in vitro drug release of multilamellar liposomes were studied. Freeze-dried liposomal products were prepared with or without cryoprotectants. Results showed that incorporation of stearylamine resulted in an increased entrapment of fluconazole, whereas incorporation of dicetyl phosphate decreased the drug entrapment efficiency. The incorporation of α-tocopherol acetate into fluconazole multilamellar liposomes resulted in the increase of entrapment efficiency of fluconazole liposomes. In vitro release studies revealed that incorporation of cholesterol into multilamellar liposomal formulations decreased drug permeability from formulations. Positively charged fluconazole multilamellar liposomes gave rise to a slow release rate compared to neutral liposomes whereas negatively charged fluconazole liposomes showed a rapid release rate. Physical stability studies showed that lyophilized cake of liposomes without cryoprotectants was compact and difficult to reconstitute compared to fluffy easily reconstituted cakes upon using cryoprotectants. Fluconazole retained in freeze-dried liposomes without cryoprotectants was 63.452% compared to 91.877% using three grams of trehalose as a cryoprotectant per gram lipid in positively charged multilamellar liposomes. Physical stability studies showed superior potentials of the lyophilized product after reconstitution in comparison with those of a solution product.

Entities:  

Keywords:  Fluconazole; Freeze-drying; Multilamellar liposomes; Ophthalmic; Stability

Year:  2010        PMID: 23960730      PMCID: PMC3730971          DOI: 10.1016/j.jsps.2010.07.003

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  20 in total

Review 1.  Fungal and parasitic infections of the eye.

Authors:  S A Klotz; C C Penn; G J Negvesky; S I Butrus
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Severe fungal keratitis treated with subconjunctival fluconazole.

Authors:  Safiye Yilmaz; Ahmet Maden
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

3.  Multilamellar liposomes of triamcinolone acetonide: preparation, stability, and characterization.

Authors:  B Clares; V Gallardo; M M Medina; Ma A Ruiz
Journal:  J Liposome Res       Date:  2009       Impact factor: 3.648

4.  Encapsulation and stability of clofazimine liposomes.

Authors:  V B Patel; A N Misra
Journal:  J Microencapsul       Date:  1999 May-Jun       Impact factor: 3.142

5.  Preparations of liposomal fluconazole and their in vitro antifungal activity.

Authors:  M Singh; M P Singh; S N Maiti; A Gandhi; R G Micetich; H Atwal
Journal:  J Microencapsul       Date:  1993 Apr-Jun       Impact factor: 3.142

6.  Penetration of topical fluconazole into human aqueous humor.

Authors:  O E Abbasoğlu; B M Hoşal; B Sener; N Erdemoğlu; E Gürsel
Journal:  Exp Eye Res       Date:  2001-02       Impact factor: 3.467

7.  In vitro stability of liposomes in the presence of polymers, trehalose and sodium taurocholate.

Authors:  T P Assadullahi; K Hamid; R C Hider
Journal:  J Microencapsul       Date:  1992 Jul-Sep       Impact factor: 3.142

8.  Physical stability of different liposome compositions obtained by extrusion method.

Authors:  X Armengol; J Estelrich
Journal:  J Microencapsul       Date:  1995 Sep-Oct       Impact factor: 3.142

9.  Study of azathioprine encapsulation into liposomes.

Authors:  M Gulati; M Grover; M Singh; S Singh
Journal:  J Microencapsul       Date:  1998 Jul-Aug       Impact factor: 3.142

10.  Topical fluconazole for experimental candida keratitis in rabbits.

Authors:  W Behrens-Baumann; B Klinge; R Rüchel
Journal:  Br J Ophthalmol       Date:  1990-01       Impact factor: 4.638

View more
  18 in total

1.  Encapsulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in liposomes prepared by thin film hydration and their transfer to mesenchymal stem cells and cord blood hematopoietic stem cells.

Authors:  Sławomir Lewicki; Monika Leśniak; Agnieszka Sobolewska-Ruta; Aneta Lewicka; Marta Grodzik; Eugeniusz K Machaj; Marek Saracyn; Jacek Z Kubiak; Zygmunt Pojda
Journal:  Arch Med Sci       Date:  2020-04-18       Impact factor: 3.707

2.  Stress impact of liposomes loaded with ciprofloxacin on the expression level of MepA and NorB efflux pumps of methicillin-resistant Staphylococcus aureus.

Authors:  Ahmed Hassan Ibrahim Faraag; Medhat W Shafaa; Nourhan S Elkholy; Lina Jamil M Abdel-Hafez
Journal:  Int Microbiol       Date:  2021-11-25       Impact factor: 3.097

Review 3.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

Review 4.  Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy.

Authors:  Hsin-I Chang; Ming-Kung Yeh
Journal:  Int J Nanomedicine       Date:  2011-12-30

Review 5.  To Protect and to Preserve: Novel Preservation Strategies for Extracellular Vesicles.

Authors:  Gina D Kusuma; Mehri Barabadi; Jean L Tan; David A V Morton; Jessica E Frith; Rebecca Lim
Journal:  Front Pharmacol       Date:  2018-10-29       Impact factor: 5.810

6.  Preparation and characterization of cefditoren pivoxil-loaded liposomes for controlled in vitro and in vivo drug release.

Authors:  Gojjala Venugopalarao; Rajasekhar Lakshmipathy; Nallani Chakravarthula Sarada
Journal:  Int J Nanomedicine       Date:  2015-10-01

7.  Formulation and in Vitro, ex Vivo and in Vivo Evaluation of Elastic Liposomes for Transdermal Delivery of Ketorolac Tromethamine.

Authors:  Guadalupe Nava; Elizabeth Piñón; Luis Mendoza; Néstor Mendoza; David Quintanar; Adriana Ganem
Journal:  Pharmaceutics       Date:  2011-12-15       Impact factor: 6.321

8.  A quality by design approach for the development of lyophilized liposomes with simvastatin.

Authors:  Alina Porfire; Dana Maria Muntean; Lucia Rus; Bianca Sylvester; Ioan Tomuţă
Journal:  Saudi Pharm J       Date:  2017-02-09       Impact factor: 4.330

9.  Investigating the Potential of Transmucosal Delivery of Febuxostat from Oral Lyophilized Tablets Loaded with a Self-Nanoemulsifying Delivery System.

Authors:  Yasir A Al-Amodi; Khaled M Hosny; Waleed S Alharbi; Martin K Safo; Khalid M El-Say
Journal:  Pharmaceutics       Date:  2020-06-10       Impact factor: 6.321

10.  Design and development of a biorelevant simulated human lung fluid.

Authors:  Mireille Hassoun; Paul G Royall; Mark Parry; Richard D Harvey; Ben Forbes
Journal:  J Drug Deliv Sci Technol       Date:  2018-10       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.